2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $121M | $144M | $546M | $794M | $895M |
Cost of Revenue | $139M | $136M | $463M | $704M | $762M |
Gross Profit | -$18M | $8.4M | $84M | $90M | $133M |
Gross Profit % | -15% | 5.9% | 15% | 11% | 15% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$280M | -$69M | $53M | -$3M | $73M |
Dep. & Amort. | $24M | $22M | $22M | $22M | $24M |
Def. Tax | $1.6M | $89K | -$181K | -$5.5M | $1.1M |
Stock Comp. | $5M | $11M | $13M | $10M | $9.1M |
Chg. in WC | $15M | -$8M | -$10M | -$1.5M | -$23M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $42M | $31M | $32M | $28M | $57M |
ST Investments | $0 | $0 | $3.1M | $0 | $0 |
Cash & ST Inv. | $42M | $31M | $32M | $28M | $57M |
Receivables | $3M | $19M | $34M | $41M | $46M |
Inventory | $27M | $29M | $40M | $48M | $47M |
OSW reported Q1 2025 revenues of $219.6M, up 4% year-over-year, and adjusted EBITDA of $26.6M (up 5%), both at the high end of guidance; adjusted net income was $22.6M ($0.22 per diluted share).
The company reaffirmed its full-year 2025 guidance: total revenue of $950M–$970M and adjusted EBITDA of $115M–$125M; Q2 2025 guidance is for revenue of $235M–$240M and adjusted EBITDA of $28M–$30M.
OSW continues to see strong demand and no signs of consumer spending slowdown onboard ships, with high-end MediSpa services and pre-booking rates (23% of services) remaining robust into April.
The company expanded its cruise partnerships, adding new ships and agreements (including with Norwegian, P&O, and Cunard), and continues to roll out new high-value services and technologies, driving over 20% growth in MediSpa treatments.
OSW strengthened its capital structure, ending Q1 with $23.8M in cash, full availability on a $50M revolver, and a new $75M share repurchase program after returning $42M to shareholders in Q1 through dividends and buybacks.